Kashyap Patel elected president of COA

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Kashyap Patel was elected president of the Community Oncology Alliance.

Patel, a long-time COA board member, is a full-time practicing medical oncologist and CEO of Carolina Blood and Cancer Care in Rock Hill, South Carolina. He began his one year term Jan. 1.

Patel is board certified in hematology, oncology, and internal medicine. In addition to his work with COA and its committees, he volunteers with other national cancer and quality organizations.

Patel has extensive expertise in value-based care, including having successfully led multiple oncology payment pilots. He has a special interest in health care policy, racial and ethnic disparities, and end of life care.

Miriam Atkins, a practicing medical oncologist at Augusta Oncology in Georgia, was named vice president of the COA board. Debra Patt, a practicing medical oncologist and executive vice president, policy and strategic initiatives at Texas Oncology in Austin, was named secretary of the board.

Emily Touloukian, a practicing medical oncologist and president-elect at Coastal Cancer Center, was also named to the board.

The nominations were completed during a regularly scheduled board meeting on Monday, Dec. 14, 2020. All board of director positions are three-year terms. These new elections became effective Jan. 1, and will end Dec. 31, 2023.

Table of Contents

YOU MAY BE INTERESTED IN

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login